Healthcare Press

Blood test to detect colon cancer could move a step closer to FDA approval in the US

  • 📰 WGAL
  • ⏱ Reading Time:
  • 17 sec. here
  • 5 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 59%

Blood Test News

Colon Cancer,FDA Approval,Shnd

Guardant Health’s Shield tests could be the first approved blood screening test for colorectal cancer that meets requirements for Medicare reimbursement.

To screen for colon and rectal cancers, most people have colonoscopies, which can feel invasive and require anesthesia, or they may take an at-home stool test, which can be more convenient but also awkward — and not appealing for the squeamish.But a simple blood test could soon become more broadly available.Palo Alto, California-based biotechnology company Guardant Health has applied for U.S.

Smith plans to watch the FDA panel meeting Thursday, but the advisers’ decision will not immediately change or shift the American Cancer Society’s screening recommendations, he said.“The American Cancer Society typically looks for FDA approval at this higher level before we would include a test in our guidelines,” Smith said.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 331. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA panel recommends approval of a blood test for colon cancerReuters
Source: NBCNewsHealth - 🏆 707. / 51 Read more »

Stocks making the biggest moves premarket: Ross Stores, Intuit, Workday, Guardant Health and moreThese are the stocks posting the largest moves in premarket trading.
Source: CNBC - 🏆 12. / 72 Read more »